New implant could replace monthly shots for opioid addiction
NCT ID NCT07064564
First seen Feb 05, 2026 · Last updated Apr 30, 2026 · Updated 13 times
Summary
This study tests an implant called iSTEP-N that releases naltrexone over many months to block opioids. It involves 33 healthy adults aged 18-55, comparing two implant doses to monthly Vivitrol injections. The goal is to see if the implant can provide steady medication levels and reduce the need for frequent shots.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.